Results

Total Results: 1,117 records

Showing results for "choice".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
    February 16, 2022 - Table F-5. Can. Cohort Studies Table F-5. Cannabis cohort studies PMID Author, Year Study Design Setting Pain Population Pain Condition Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, Other % Pain Duration Measure (Mean, Median) Pain Duration, Mon…
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
    November 04, 2021 - Table E-5. Can. Cohort Studies Table E-5. Cannabis cohort studies PMID Author, Year Study Design Setting Pain Population Pain Condition Age Measure (Mean, Median) Age, years Female % Race, White % Race, Black % Race, Hispanic/Latino % Race, Asian % Race, other % Pain Duration Measure (Mean, Median) Pain Duration, Mon…
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-surveillance-2-report.pdf
    October 01, 2020 - Masks for Prevention of COVID-19 in Community and Healthcare Settings: Surveillance Report Surveillance Report: October 2020 Masks for Prevention of COVID-19 in Community and Healthcare Settings: Surveillance Report Background This surveillance report summarizes the search and update for the rapid review and li…
  4. effectivehealthcare.ahrq.gov/products/allergy-seasonal/research-protocol
    March 08, 2012 - Adverse effects, such as sedation, are therefore reduced. 27 The choice of which antihistamine to use … For children who are able and willing to use intranasal medication, nasal saline presents a treatment choice
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
    January 31, 2013 - The initial test of choice includes the simple ABI measurement. … A number of trials have addressed the questions of aspirin dose and choice of antiplatelet strategy, … trials, as well as other published literature, is needed to determine the aspirin dose and optimal choice … Given these issues, the choice of revascularization strategy (endovascular versus surgical) is often
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_executive.pdf
    December 01, 2012 - 1 Comparative Effectiveness Review Number 88 Evaluation and Treatment of Cryptorchidism Executive Summary Background Cryptorchidism is a congenital condition in which one or both testicles are not appropriately positioned in the scrotum at birth and cannot be moved into the proper position manually. The term …
  7. effectivehealthcare.ahrq.gov/sites/default/files/assessing-quality.ppt
    January 01, 2010 - attributable to chance Inferential Errors: Result from problems in data analysis and interpretation, such as choice
  8. effectivehealthcare.ahrq.gov/sites/default/files/hibbard-presentation.pdf
    November 11, 2015 - approach. 19 What arethe implications for all of this for supporting theuseof information  and   choice
  9. effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-case-130621.pdf
    June 01, 2013 - All teams were required to use the AHRQ Health Literacy report, but had a choice to couple content from … The choice may be influenced by the recommendations of strategic advisors, the host’s resources and
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
    February 01, 2010 - are similar after CABG and PCI in most patient subgoups with multivessel coronary artery disease, so choice … effectiveness, since the extent of coronary disease is the strongest clinical factor affecting the choice
  11. effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-webinar-transcript.pdf
    June 01, 2014 - Teams had the choice of basing their resources on evidence from  either the acute otitis media updates
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-value-of-information_research.pdf
    June 01, 2011 - VOI Results When we based our treatment choice decisions on duration of symptoms only, the baseline … Below that threshold, gemcitabine alone is the cost-effective treatment of choice. … VOI Results When we based our treatment choice decisions on effectiveness only, the population value
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
    February 01, 2012 - for a rapidly progressing lysosomal storage disorder such as Wolman’s syndrome are clear; this is a choice
  14. effectivehealthcare.ahrq.gov/products/major-depressive-disorder/research-protocol
    June 19, 2014 - This review will focus on two key issues facing primary care physicians: As an initial treatment choice … These options include adding a pharmacologic or nonpharmacologic treatment to the initial medication choice
  15. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_executive.pdf
    December 01, 2011 - Therefore, our findings indicate that the existing evidence does not warrant the choice of one second … Nonetheless, some of these differences may be clinically significant and influence the choice of a medication
  16. effectivehealthcare.ahrq.gov/products/depression-harms/research-protocol
    February 07, 2018 - reported; thus, we will consider use of methods such as the Peto or Mantel-Haenzel odds ratios. 14 The choice
  17. Schwitzer_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
    July 23, 2012 - Schwitzer_ECCS2012 Slide 1: Addressing  Tensions  When Popular Media and Evidence-­‐Based Care Collide Gary  Schwitzer Publisher,  HealthNewsReview.org Slide 2: Infoxication We are drowning people who are thirsty for just a sip of balanced infor…
  18. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_executive.pdf
    May 01, 2010 - Layout 1 Background Head and neck cancers, specifically those arising in the oral cavity, larynx, hypopharynx, oropharynx, nasopharynx, paranasal sinuses/nasal cavity, salivary glands, and occult primaries, account for approximately 3 to 5 percent of cancers in the United States. According to the National Comprehens…
  19. effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
    December 29, 2020 - I had no other choice than to go on Suboxone. I was dependant on Opioids not addicted to them. … more subtle reporting biases found in this report is that opioids are rarely a treatment of first choice … unrelieved pain and introduces the notion that postoperative analgesia is not a matter of a simple choice … Issues related to choice of outcome tools and corporate sponsorship further complicate interpretation … Issues related to choice of outcome tools and corporate sponsorship further complicate interpretation
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-disposition.pdf
    June 22, 2017 - the definition of sufficient evidence excludes level I therapeutic evidence for aspirin; (2) the choice … Discussion we do talk about the possibility of bias related to selective outcome reporting and selective choice … We would instead suggest that industry bias (in choice of outcomes and interventions) is made more … Conduct sensitivity analysis using either model to see how the model choice might impact the outcomes

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: